SCHEMBL15380779

SCHEMBL15380779

CCCCCCCCCCCCCCC(C)OCC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.50
FAAH O00519 5/20 0.43
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
SPHK1 Q9NYA1 1/20 0.41
LMNA P02545 2/20 0.41
DNM1 Q05193 2/20 0.40
TSHR P16473 1/20 0.40
THRB P10828 1/20 0.40
TP53 P04637 1/20 0.40
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
SMPD1 P17405 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22649557 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL28813965 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL471924 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL6425397 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL3316528 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL24090459 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL3317092 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL5538153 1.00 OPRM1 (0.50) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL610212 0.97 OPRM1 (0.52) OPRM1FAAHCNR1CNR2SPHK1
SCHEMBL18106104 0.97 OPRM1 (0.52) OPRM1FAAHCNR1CNR2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104655828-B System, the method and apparatus of diagnosis based on tissue 加州大学评议会 2018-04-27 CN claimed
WO-2024091258-A1 ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS- COV-2 VACCINES COMPOSITION AND METHODS D4 LABS, LLC (US) 2024-05-02 WO disclosed
US-20240131139-A1 ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS-COV-2 VACCINES COMPOSITION AND METHODS D4 LABS, LLC 2024-04-25 US disclosed
US-11911461-B1 Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use D4 LABS, LLC (US) 2024-02-27 US disclosed
CN-104655828-B System, the method and apparatus of diagnosis based on tissue 加州大学评议会 2018-04-27 CN disclosed
US-20130298946-A1 PRETREATMENT COMPOSITION AND METHOD INNOVATION SERVICES, INC. 2013-11-14 US disclosed